THE STATE OF THE SIRS AND ENDOTHELIAL FUNCTION IN HYPERTENSIVE PATIENTS, STAGE II IN THE PROCESS OF ISCHEMIC HEART DISEASE DEVELOPING

Authors

  • I. M. Fushtey
  • V. A. Mochonyi
  • E. V. Sid’
  • N. F. Efimenko

DOI:

https://doi.org/10.14739/2310-1210.2015.4.50308

Keywords:

Hypertension, Myocardial Ischemia, Immuno-Inflammatory Markers, Endothelium

Abstract

Aim and Methods. Clinical and pathogenetic significance of immuno-inflammatory response in the occurrence of coronary heart disease (CHD) in patients with essential hypertension (EH) is insufficiently studied. In order to determine the concentration of immuno-inflammatory markers in the blood plasma, interleukin-1β (IL-1β), interleukin-10 (IL-10), high-sensitivity C-reactive protein (HS-CRP) and their relationship with endothelial function (according to end-point metabolites of nitric oxide and reactive hyperemia) a comprehensive study of 180 patients with stage II EH was conducted. Clinical examination, determination of serum levels of IL-1β, IL-10, HS-CRP level NO2 and NO3, endothelium-dependent vasodilation were provided.

Results and conclusion. It was discovered that level of IL-1β was significantly higher in patients with CHD in combination with EH in the group of  patients with HTN without CHD. NO2 level was significantly lower in the group of patients with CHD combined with EH. HS-CRP concentration in the group of CHD patients in combination with EH was in 1.6 times higher than in the group of EH patients without CHD. In the group of EH patients there was revealed inverse correlation between the level of IL-1β and NO2 (R = - 0,28, p = 0,001), and between levels of HS-CRP and NO2 (R = - 0,33, p = 0,001).

References

Asotsiatsiia kardiologiv Ukrainy (2012). Arterialna hipertenziia. Onovlena ta adaptovana klinichna nastanova, zasnovana na dokazakh [ArterIalna gIpertenzIya. Onovlena ta adaptovana klInIchna nastanova, zasnovana na dokazah]. Kyiv. [in Ukrainian].

(2012) Nakaz Ministerstva okhorony zdorovia Ukrainy Ishemichna khvoroba sertsia: stabilna stenokardiia napruhy vid 23 lystopada 2011 roku №816 [Order of the Ministry of Health of Ukraine Coronary heart disease: stable angina from November 23, 2012, №816]. Praktykuiuchyi likar, 1, 84–89. [in Ukrainian].

Kozhanova, T. A. (2010) Osobennosti citokinovogo profilya u bol′nykh arterial′noj gipertenziey s proyavleniyami remodelirovaniya serdca [Cytokine profile characteristics in hypertensive patients with cardiac remodelling]. Tavricheskij mediko-biologicheskij vestnik, 1(49), 102–105. [in Ukrainian].

Dmitriev, V. A., Oschepkova, E. V., Titov, V. N., Balakhonova, T. V., Tripoten', M. I., Rogoza, A. N., Shiryaeva, Yu. K. (2012) Nespecificheskoe vospalenie i strukturnye izmeneniya arterij u muzhchin s gipertonicheskoj bolezn'yu srednego i vysokogo riska razvitiya serdechno-sosudistykh oslozhnenij [The non-specific inflammation and structural changes of the arteries in men with hypertension medium and high risk for cardiovascular complications]. Terapevticheskij arkhiv, 9, 53–57. [in Russian].

Sirenko, Yu. M. (2014) Medyko-sotsialni problemy kardiolohichnoi dopomohy v Ukraini: shliakhy vyrishennia [Medical and social problems of cardiac care in Ukraine: Ways to solve] Problemy bezperervnoi medychnoi osvity ta nauky, 2, 6–10. [in Ukrainian].

Kulinich, I. A., Fushtei, I. M., & Myrnyi, D. P. (patentee) (2011) Patent 60680 «Sposib diahnostyky endotelialnoi dysfunktsii peryferychnykh sudyn» [60680 6. Patent «Method of diagnosis of peripheral vascular endothelial dysfunction»]. Kyiv. [in Ukrainian].

Shevchenko, Yu. L., Astashev, P. E., Matveev, S. A., & Goodymovich, V. G. (2011). Endotelij – strukturnaya osnova sistemy krovoobrascheniya: istoriya problem [Endothelium structural bassis of circulatory system: the history of the problem]. Vestnik nacional'nogo mediko-khirurgiсрeskogo centra im. N.I. Pirogova, 6(2), 9–15. [in Russian].

Chrysohoou, C., Pitsavos, C., Panagiotakos, D. B., Skoumas, J., & Stefanadis, C. (2004). Association between prehypertension status and inflammatory markers related to atherosclerotic disease* The ATTICA Study. American journal of hypertension, 17(7), 568–573. doi:10.1016/j.amjhyper.2004.03.675.

Harrison, D. G., Guzik, T. J., Lob, H. E., Madhur, M. S., Marvar, P. J., Thabet, S. R., et al. (2011). Inflammation, immunity, and hypertension. Hypertension, 57(2), 132–140. doi: 10.1161/HYPERTENSIONAHA.110.163576.

Schillaci, G., Pirro, M., Gemelli, F., Pasqualini, L., Vaudo, G., Marchesi, S., et al. (2003). Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. Journal of hypertension, 21(10), 1841–1846.

Bautista, L. E., Vera, L. M., Arenas, I. A., & Gamarra, G. (2005). Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension. Journal of human hypertension, 19(2), 149–154. doi: 10.1038/sj.jhh.1001785.

Chamarthi, B., Williams, G. H., Ricchiuti, V., Srikumar, N., Hopkins, P. N., Luther, J. M., et al. (2011). Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin–angiotensin system in humans. American journal of hypertension, 24(10), 1143–1148. doi: 10.1038/ajh.2011.113.

Newman, J. (2013). Multiple Risk Factor Intervention Trial (MRFIT). In Encyclopedia of Behavioral Medicine. New York.

Downloads

How to Cite

1.
Fushtey IM, Mochonyi VA, Sid’ EV, Efimenko NF. THE STATE OF THE SIRS AND ENDOTHELIAL FUNCTION IN HYPERTENSIVE PATIENTS, STAGE II IN THE PROCESS OF ISCHEMIC HEART DISEASE DEVELOPING. Zaporozhye Medical Journal [Internet]. 2015Sep.16 [cited 2024Nov.5];17(4). Available from: http://zmj.zsmu.edu.ua/article/view/50308

Issue

No. 4 (2015): Zaporozhye medical journal

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)